15d
Zacks Small Cap Research on MSNACHV: 2Q:25 NDA SubmissionAchieve Life Sciences, Inc. (NASDAQ:ACHV) reported 2024 results sharing progress with the new drug application (NDA) for ...
today announced it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Oleogel-S10, for the treatment of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results